UAB Pharmaplius Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 5,843,285 |
| 2,907,107 |
| 639,077 |
| 543,215 |
| 270,256 |
| 14.84 |
| 9.30 |
| 936,643 |
| 256,396 |
| 18,619 |
| 1,172,639 |
| 2024 |
|---|
| 15,376,630 |
| 4,418,572 |
| 2,658,469 |
| 2,259,699 |
| 649,339 |
| 21.68 |
| 14.70 |
| 1,544,342 |
| 1,068,485 |
| 126,244 |
| 2,484,827 |
| 2025 |
|---|
| 16,054,931 |
| 4,013,733 |
| 2,425,116 |
| 2,037,084 |
| 509,271 |
| 23.50 |
| 12.69 |
| 1,591,426 |
| 309,059 |
| 106,364 |
| 1,792,184 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 16,054,931 |
| 4,013,733 |
| 2,425,116 |
| 2,037,084 |
| 509,271 |
| 23.50 |
| 12.69 |
| 1,591,426 |
| 309,059 |
| 106,364 |
| 1,792,184 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
16,054,931 €4 % *
Sales per employee (€)
4,013,733 €-9 % *
Profit before tax (€)
2,425,116 €-9 % *
Net Profit (€)
2,037,084 €-10 % *
Profit per employee (€)
509,271 €-22 % *
Total profitability (%)
23.50 %8.39 % *
Net profitability (%)
12.69 %-13.67 % *
Equity (€)
1,591,426 €3 % *
Amounts Payable And Liabilities (€)
309,059 €-71 % *
Non-current Assets (€)
106,364 €-16 % *
CurrentAssets (€)
1,792,184 €-28 % *
